Secure Healthcare Information Management

Synertech Incorporated, based in Philadelphia, PA, specializes in environmental consulting and management services. Established in 1990, the company focuses on providing survey, assessment, testing, and inspection services for environmental and hazardous materials. Their expertise includes asbestos and lead program management, Indoor Air Quality (IAQ) concerns, moisture intrusion, mold growth evaluations, worksite safety compliance, and environmental auditing. Catering to a diverse clientele from public and private sectors, Synertech serves metropolitan areas of Philadelphia and surrounding PA and NJ counties. Their client base includes manufacturing and industrial firms, commercial property managers, government agencies, schools, universities, and private citizens. The company is known for its professionalism in environmental science and its ability to offer customized solutions to meet unique client needs. Synertech stands out for its dedication to excellence, high standards of quality, and a team of experienced professionals. Their services encompass testing and inspections for hazardous materials such as asbestos, lead, and mold, along with remediation planning and management. With a focus on asbestos management, lead testing, and indoor air quality evaluations, Synertech is committed to delivering results-oriented performance for their clients. Generated from the website content

Atlantic Response Inc is a 24/7 environmental services firm based in East Brunswick, NJ, specializing in emergency response for various environmental needs. The company is committed to providing high-quality services through innovative approaches and aims to establish lasting partnerships with clients across multiple sectors, including government agencies and the insurance industry. With a focus on exceeding client expectations, Atlantic Response Inc emphasizes safety, efficiency, and professionalism in all its operations. The firm aspires to cultivate a diverse client base by forging service-based relationships with key players in the environmental community. Generated from the website

CHDI Foundation is a privately-funded nonprofit biomedical research organization dedicated to accelerating the development of therapeutics for Huntington's disease (HD). By fostering collaboration among a diverse portfolio of research projects, CHDI aims to bridge the translational gap between academic and industrial research, ensuring faster access to innovative therapies for patients. With a global network of over 700 researchers and partnerships with biotech and pharmaceutical companies, CHDI provides essential resources such as clinical data, biosamples, and animal models to the HD research community. Its comprehensive approach includes managing the Enroll-HD clinical research platform, which has enrolled over 28,000 participants worldwide, facilitating smarter clinical trial designs and improved care for HD patients. Generated from the website